Thyroid Cancer Follow-Up: A Contemporary Review for the Clinician Who Wants to Do Better Than Guidelines
Thyroid Cancer Follow-Up: A Contemporary Review for the Clinician Who Wants to Do Better Than Guidelines Dr Neeraj Manikath , claude.ai Review Article | Internal Medicine & Endocrinology Targeted at Postgraduate Trainees, Registrars, and Practicing Consultants "A 34-year-old school teacher is referred to your clinic three years after total thyroidectomy and radioiodine ablation for a 2.2 cm papillary thyroid carcinoma (PTC) with a single ipsilateral lymph node metastasis. Her suppressed TSH has been maintained at 0.1 mIU/L. Her stimulated thyroglobulin (Tg) at one year was undetectable. Today, she brings her latest report — a serum Tg of 1.8 ng/mL on TSH suppression. She is anxious. Are you?" This vignette — deceptively simple, dangerously easy to mishandle — captures the essence of thyroid cancer follow-up. The disease is common, mostly indolent, yet riddled with clinical nuance. Done well, follow-up transforms outcomes and avoids over-treatment. Done poorly, it...